Events2Join

Cases in TK2d Care


Hear Patient's Experiences Living With TK2d

Watch videos of patients who live with thymidine kinase 2 deficiency (TK2d) as they share their stories and discuss the impact of TK2d on their day-to-day ...

Annenberg Center for Health Sciences

... patients to specialized mitochondrial treatment centers and explores vital aspects of supportive care. ... patients with TK2d. Supported by an independent ...

Muscle MRI characteristic pattern for late-onset TK2 deficiency ...

In patients with TK2d, oral treatment with thymidine and deoxycytidine nucleosides has shown to prolong survival in the most severe ...

Testing for TK2d | Diagnose TK2d with Genetic Testing

Another reason why it can take so long is that many disorders and diseases have symptoms similar to TK2d (such as muscular dystrophy, Pompe disease, and others) ...

EX-99.1 - SEC.gov

A pivotal Phase 2 retrospective treatment study (called RETRO) of MT1621 substrate enhancement therapy in patients with TK2d was recently completed, with ...

Zogenix Supports New No-Cost Genetic Testing Program with ...

The UMDF program will include testing for the TK2 gene.TK2d is a debilitating and life-threatening genetic disorder that causes progressive and ...

Collaborative model for diagnosis and treatment of very rare diseases

Here, we describe a unique collaborative practice model among physicians and scientists in Spain focused on identifying TK2 deficiency (TK2d), an ultra-rare ...

A RETROspective Study of Patients With TK2d

This is a medical chart review study to collect information for patients who have been taking pyrimidine nucleosides for treatment of TK2 ...

Advances in Thymidine Kinase 2 Deficiency: Clinical Aspects ...

Oral treatment of the Tk2 H126N knock- in mouse ... Hyper- trophic cardiomyopathy is rare in TK2d and has been reported in only 3 cases.

Collaborative model for diagnosis and treatment of very rare diseases

This unique collaboration in Spain has led to the diagnosis of more than 30 patients with genetically confirmed TK2d across different regions of ...

Mitochondrial DNA depletion syndrome (MDDS)

For example, there are thought to be <100 cases of mitochondrial DNA depletion syndrome associated with the TK2 mutation throughout the world. The ...

Zogenix Presents Positive Clinical Study Results for - GlobeNewswire

Parallel to RETRO, the Company compiled a comprehensive, global TK2d Natural History dataset from published studies and individual case reports ...

Neuromuscular Disorders - Repositorio Institucional de la

Based on preclinical studies in mice [3,16], patients with TK2d began receiving nucleoside treatment under ... Adult cases · of mitochondrial DNA depletion due to ...

Recommendations for treatment of mitochondrial DNA ... - ENMC

treatment in TK2d patients [42], followed by current ongoing clinical trials for this therapy (NCT03845712 and NCT04581733). Additional reports have ...

Mitochondrial disease awareness week - Rare Revolution Magazine

It was the second such call in as many years. In January 2022, the FDA held a similar session for thymidine kinase 2 deficiency (TK2d) , another ...

Potential Therapy for TK2 Deficiency Shows Positive Results

A retrospective study of nucleoside therapy for treating the very rare mitochondrial disorder thymidine kinase 2 deficiency (TK2d) has shown positive results.

Muscle MRI characteristic pattern for late-onset TK2 deficiency ...

In patients with TK2d, oral treatment with thymidine and deoxycytidine nucleo- sides has shown to prolong survival in the most severe infan ...

Mitochondrial Chronic Progressive External Ophthalmoplegia - MDPI

Patients with late-onset TK2d have the characteristic progressive proximal muscle wasting, with the addition of axial neck flexors and facial weakness. This ...

Collaborative model for diagnosis and treatment of very rare ...

... care for patients with TK2d. The incidence of TK2d is not known; however, the first clinical cases of TK2d were reported in 2001, and only ~ 107 unique ...

Charlie Gard case - Wikipedia

The case became controversial because the medical team and parents disagreed about whether experimental treatment was in the best interests of the child.